Monoclonal antibody and assay for detecting PIIINP
View Patent ↗The present invention relates to monoclonal antibodies binding to the N-terminal procollagen (III) propeptide (PIIINP) molecule which is a proteolytic fragment emanating from the specific cleavage of procollagen (III) by N-proteinase after exocytosis and to an assay using these antibodies.
1. A monoclonal antibody directed against an epitope within the 30 most N-terminal amino acids of the Col1 domain of human PIIINP, wherein the sequence of the 30 most N-terminal amino acids is Gln-Glu-Ala-Val-Glu-Gly-Gly-Cys-Ser-His-Leu-Gly-Gln-Ser-Tyr-Ala-Asp-Arg-Asp-Val-Trp-Lys-Pro-Glu-Pro-Cys-Gln-Ile-Cys-Val (amino acids 25 to 54 of SEQ ID NO 2).
2. The monoclonal antibody according to claim 1 , wherein the antibody is characterized by preferentially binding to trimeric PIIINP as compared to monomeric col1 domain.
3. A monoclonal antibody produced from the mAb 35J22 cell line (ATCC PTA-9545).
4. A monoclonal antibody bound to a support; said monoclonal antibody being directed against an epitope within the 30 most N-terminal amino acids of the Col1 domain of human PIIINP, the sequence of the 30 most N-terminal amino acids being Gln-Glu-Ala-Val-Glu-Gly-Gly-Cys-Ser-His-Leu-Gly-Gln-Ser-Tyr-Ala-Asp-Arg-Asp-Val-Trp-Lys-Pro-Glu-Pro-Cys-Gln-Ile-Cys-Val (amino acids 25 to 54 of SEQ ID NO 2).
5. A monoclonal antibody produced from the mAb 35J22 cell line (ATCC PTA-9545) bound to a support.